Kittiyod Poovorawan
Overview
Explore the profile of Kittiyod Poovorawan including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
68
Citations
459
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Watson J, Mehdipour P, Moss R, Jittamala P, Zaloumis S, Price D, et al.
Antimicrob Agents Chemother
. 2025 Feb;
:e0154924.
PMID: 39992119
Primaquine is the only widely available drug to prevent relapses of malaria. Primaquine is underused because of concerns over oxidant hemolysis in glucose-6-phosphate dehydrogenase (G6PD) deficiency. A pharmacometric trial showed...
2.
Jittamala P, Boyd S, Schilling W, Watson J, Ngamprasertchai T, Siripoon T, et al.
EClinicalMedicine
. 2025 Feb;
80:103036.
PMID: 39896880
Background: The selective serotonin reuptake inhibitors (SSRIs) fluoxetine and fluvoxamine were repurposed for the treatment of early COVID-19 based on their antiviral activity , and observational and clinical trial evidence...
3.
Decharatanachart P, Poovorawan K, Tangkijvanich P, Charatcharoenwitthaya P, Peeraphatdit T, Taychakhoonavudh S, et al.
Am J Gastroenterol
. 2025 Jan;
PMID: 39878449
Background Aims: Non-invasive tests (NITs), e.g. Fibrosis-4 Index (FIB-4) and vibration-controlled elastography (VCTE), have been used to identify metabolic dysfunction-associated steatotic liver disease (MASLD) patients at high risks for hepatocellular...
4.
Koompapong K, Popruk S, Reamtong O, Thiangtrongjit T, Ampawong S, Sakulpanich A, et al.
Heliyon
. 2025 Jan;
11(1):e41530.
PMID: 39866421
is a major pathogen of the gastrointestinal tract, and infections impact both human health and the economy. The ongoing issues with drug resistance and the side effects of current anti-...
5.
Hongsuwong T, Khemrattrakool P, Phanphoowong T, Sriwichai P, Poovorawan K, Tarning J, et al.
Med Vet Entomol
. 2025 Jan;
PMID: 39831727
Mass ivermectin (IVM) treatment of livestock (MITL) is under consideration as a malaria control tool as IVM-treated livestock are lethal to blood-feeding Anopheles mosquitoes. MITL is routinely used as a...
6.
Khemrattrakool P, Hongsuwong T, Phanphoowong T, Sriwichai P, Poovorawan K, Tarning J, et al.
Malar J
. 2025 Jan;
24(1):9.
PMID: 39815344
Background: Emodepside is an anthelmintic used in veterinary medicine that is currently under investigation in human clinical trials for the treatment of soil-transmitted helminths and possibly Onchocerca volvulus. Emodepside targets...
7.
Kanokudom S, Poovorawan K, Nilyanimit P, Suntronwong N, Aeemjinda R, Honsawek S, et al.
PLoS One
. 2024 Nov;
19(11):e0313771.
PMID: 39556526
Hepatitis C virus (HCV) infection can cause acute and chronic hepatitis, leading to liver cirrhosis and hepatocellular carcinoma. The World Health Organization aims to eliminate viral hepatitis by 2030 through...
8.
Astley J, Saralamba S, Poovorawan K, White L, Aguas R, Pan-Ngum W
PLoS One
. 2024 Oct;
19(10):e0309313.
PMID: 39413060
Background: Hepatitis C Virus is endemic to many areas of Thailand, whose population structure is tending towards older age groups as birth rate and mortality decrease. With around 790,000 cases...
9.
Hanboonkunupakarn B, Mukaka M, Jittamala P, Poovorawan K, Pongsuwan P, Stockdale L, et al.
NPJ Vaccines
. 2024 Jul;
9(1):124.
PMID: 38971837
In preparation for mass vaccinations with R21/Matrix-M™ combined with mass administrations of dihydroartemisinin, piperaquine, and a single low dose primaquine we assessed the tolerability, safety, and potential interactions of this...
10.
Wongnak P, Schilling W, Jittamala P, Boyd S, Luvira V, Siripoon T, et al.
Lancet Infect Dis
. 2024 Apr;
24(9):953-963.
PMID: 38677300
Background: Effective antiviral drugs prevent hospitalisation and death from COVID-19. Antiviral efficacy can be efficiently assessed in vivo by measuring rates of SARS-CoV-2 clearance estimated from serial viral genome densities...